Disrupting Dengue with an Emerging Markets Launch Strategy SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
Leadership & Managing People
Strategy / MBA Resources
Case Study SWOT Analysis Solution
Case Study Description of Disrupting Dengue with an Emerging Markets Launch Strategy
Sanofi Pasteur's newly approved dengue vaccine, Dengvaxia, was unusual in that it was launched in the Philippines and other at-risk countries. By choosing to "flip the model" - launch in an emerging market setting as opposed to developed markets - it had to overcome various obstacles across the value chain, from registration to financing to supply. The company spent 20 years and invested $1.7 billion to develop Dengvaxia, taking several high-risk decisions and making trade-offs along the way. The case highlights the stakeholder interdependencies and uncertainties that remained as the vaccine implementation programme crept closer. If successfully resolved, it could potentially offer a blueprint for others.
Swot Analysis of "Disrupting Dengue with an Emerging Markets Launch Strategy" written by Stephen E. Chick, Ridhima Aggarwal includes – strengths weakness that are internal strategic factors of the organization, and opportunities and threats that Dengvaxia Dengue facing as an external strategic factors. Some of the topics covered in Disrupting Dengue with an Emerging Markets Launch Strategy case study are - Strategic Management Strategies, Emerging markets, Product development, Risk management and Leadership & Managing People.
Some of the macro environment factors that can be used to understand the Disrupting Dengue with an Emerging Markets Launch Strategy casestudy better are - – increasing energy prices, increasing transportation and logistics costs, central banks are concerned over increasing inflation, competitive advantages are harder to sustain because of technology dispersion, talent flight as more people leaving formal jobs, increasing commodity prices, banking and financial system is disrupted by Bitcoin and other crypto currencies,
there is backlash against globalization, increasing inequality as vast percentage of new income is going to the top 1%, etc
Introduction to SWOT Analysis of Disrupting Dengue with an Emerging Markets Launch Strategy
SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University , we believe that protagonist in Disrupting Dengue with an Emerging Markets Launch Strategy case study can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Dengvaxia Dengue, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Dengvaxia Dengue operates in.
According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.
SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix
SWOT analysis of Disrupting Dengue with an Emerging Markets Launch Strategy can be done for the following purposes –
1. Strategic planning using facts provided in Disrupting Dengue with an Emerging Markets Launch Strategy case study
2. Improving business portfolio management of Dengvaxia Dengue
3. Assessing feasibility of the new initiative in Leadership & Managing People field.
4. Making a Leadership & Managing People topic specific business decision
5. Set goals for the organization
6. Organizational restructuring of Dengvaxia Dengue
Strengths Disrupting Dengue with an Emerging Markets Launch Strategy | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The strengths of Dengvaxia Dengue in Disrupting Dengue with an Emerging Markets Launch Strategy Harvard Business Review case study are -
Successful track record of launching new products
– Dengvaxia Dengue has launched numerous new products in last few years, keeping in mind evolving customer preferences and competitive pressures. Dengvaxia Dengue has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network.
Low bargaining power of suppliers
– Suppliers of Dengvaxia Dengue in the sector have low bargaining power. Disrupting Dengue with an Emerging Markets Launch Strategy has further diversified its suppliers portfolio by building a robust supply chain across various countries. This helps Dengvaxia Dengue to manage not only supply disruptions but also source products at highly competitive prices.
Ability to recruit top talent
– Dengvaxia Dengue is one of the leading recruiters in the industry. Managers in the Disrupting Dengue with an Emerging Markets Launch Strategy are in a position to attract the best talent available. The firm has a robust talent identification program that helps in identifying the brightest.
Sustainable margins compare to other players in Leadership & Managing People industry
– Disrupting Dengue with an Emerging Markets Launch Strategy firm has clearly differentiated products in the market place. This has enabled Dengvaxia Dengue to fetch slight price premium compare to the competitors in the Leadership & Managing People industry. The sustainable margins have also helped Dengvaxia Dengue to invest into research and development (R&D) and innovation.
Superior customer experience
– The customer experience strategy of Dengvaxia Dengue in the segment is based on four key concepts – personalization, simplification of complex needs, prompt response, and continuous engagement.
High brand equity
– Dengvaxia Dengue has strong brand awareness and brand recognition among both - the exiting customers and potential new customers. Strong brand equity has enabled Dengvaxia Dengue to keep acquiring new customers and building profitable relationship with both the new and loyal customers.
Innovation driven organization
– Dengvaxia Dengue is one of the most innovative firm in sector. Manager in Disrupting Dengue with an Emerging Markets Launch Strategy Harvard Business Review case study can use Clayton Christensen Disruptive Innovation strategies to further increase the scale of innovtions in the organization.
Highly skilled collaborators
– Dengvaxia Dengue has highly efficient outsourcing and offshoring strategy. It has resulted in greater operational flexibility and bringing down the costs in highly price sensitive segment. Secondly the value chain collaborators of the firm in Disrupting Dengue with an Emerging Markets Launch Strategy HBR case study have helped the firm to develop new products and bring them quickly to the marketplace.
Analytics focus
– Dengvaxia Dengue is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure suggested by Stephen E. Chick, Ridhima Aggarwal can also help it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.
Effective Research and Development (R&D)
– Dengvaxia Dengue has innovation driven culture where significant part of the revenues are spent on the research and development activities. This has resulted in, as mentioned in case study Disrupting Dengue with an Emerging Markets Launch Strategy - staying ahead in the industry in terms of – new product launches, superior customer experience, highly competitive pricing strategies, and great returns to the shareholders.
Organizational Resilience of Dengvaxia Dengue
– The covid-19 pandemic has put organizational resilience at the centre of everthing that Dengvaxia Dengue does. Organizational resilience comprises - Financial Resilience, Operational Resilience, Technological Resilience, Organizational Resilience, Business Model Resilience, and Reputation Resilience.
Learning organization
- Dengvaxia Dengue is a learning organization. It has inculcated three key characters of learning organization in its processes and operations – exploration, creativity, and expansiveness. The work place at Dengvaxia Dengue is open place that encourages instructiveness, ideation, open minded discussions, and creativity. Employees and leaders in Disrupting Dengue with an Emerging Markets Launch Strategy Harvard Business Review case study emphasize – knowledge, initiative, and innovation.
Weaknesses Disrupting Dengue with an Emerging Markets Launch Strategy | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The weaknesses of Disrupting Dengue with an Emerging Markets Launch Strategy are -
Low market penetration in new markets
– Outside its home market of Dengvaxia Dengue, firm in the HBR case study Disrupting Dengue with an Emerging Markets Launch Strategy needs to spend more promotional, marketing, and advertising efforts to penetrate international markets.
Slow to strategic competitive environment developments
– As Disrupting Dengue with an Emerging Markets Launch Strategy HBR case study mentions - Dengvaxia Dengue takes time to assess the upcoming competitions. This has led to missing out on atleast 2-3 big opportunities in the industry in last five years.
Skills based hiring
– The stress on hiring functional specialists at Dengvaxia Dengue has created an environment where the organization is dominated by functional specialists rather than management generalist. This has resulted into product oriented approach rather than marketing oriented approach or consumers oriented approach.
High dependence on star products
– The top 2 products and services of the firm as mentioned in the Disrupting Dengue with an Emerging Markets Launch Strategy HBR case study still accounts for major business revenue. This dependence on star products in has resulted into insufficient focus on developing new products, even though Dengvaxia Dengue has relatively successful track record of launching new products.
High dependence on existing supply chain
– The disruption in the global supply chains because of the Covid-19 pandemic and blockage of the Suez Canal illustrated the fragile nature of Dengvaxia Dengue supply chain. Even after few cautionary changes mentioned in the HBR case study - Disrupting Dengue with an Emerging Markets Launch Strategy, it is still heavily dependent upon the existing supply chain. The existing supply chain though brings in cost efficiencies but it has left Dengvaxia Dengue vulnerable to further global disruptions in South East Asia.
Slow decision making process
– As mentioned earlier in the report, Dengvaxia Dengue has a very deliberative decision making approach. This approach has resulted in prudent decisions, but it has also resulted in missing opportunities in the industry over the last five years. Dengvaxia Dengue even though has strong showing on digital transformation primary two stages, it has struggled to capitalize the power of digital transformation in marketing efforts and new venture efforts.
High cash cycle compare to competitors
Dengvaxia Dengue has a high cash cycle compare to other players in the industry. It needs to shorten the cash cycle by 12% to be more competitive in the marketplace, reduce inventory costs, and be more profitable.
High operating costs
– Compare to the competitors, firm in the HBR case study Disrupting Dengue with an Emerging Markets Launch Strategy has high operating costs in the. This can be harder to sustain given the new emerging competition from nimble players who are using technology to attract Dengvaxia Dengue 's lucrative customers.
Interest costs
– Compare to the competition, Dengvaxia Dengue has borrowed money from the capital market at higher rates. It needs to restructure the interest payment and costs so that it can compete better and improve profitability.
Aligning sales with marketing
– It come across in the case study Disrupting Dengue with an Emerging Markets Launch Strategy that the firm needs to have more collaboration between its sales team and marketing team. Sales professionals in the industry have deep experience in developing customer relationships. Marketing department in the case Disrupting Dengue with an Emerging Markets Launch Strategy can leverage the sales team experience to cultivate customer relationships as Dengvaxia Dengue is planning to shift buying processes online.
Need for greater diversity
– Dengvaxia Dengue has taken concrete steps on diversity, equity, and inclusion. But the efforts so far has resulted in limited success. It needs to expand the recruitment and selection process to hire more people from the minorities and underprivileged background.
Opportunities Disrupting Dengue with an Emerging Markets Launch Strategy | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The opportunities highlighted in the Harvard Business Review case study Disrupting Dengue with an Emerging Markets Launch Strategy are -
Identify volunteer opportunities
– Covid-19 has impacted working population in two ways – it has led to people soul searching about their professional choices, resulting in mass resignation. Secondly it has encouraged people to do things that they are passionate about. This has opened opportunities for businesses to build volunteer oriented socially driven projects. Dengvaxia Dengue can explore opportunities that can attract volunteers and are consistent with its mission and vision.
Redefining models of collaboration and team work
– As explained in the weaknesses section, Dengvaxia Dengue is facing challenges because of the dominance of functional experts in the organization. Disrupting Dengue with an Emerging Markets Launch Strategy case study suggests that firm can utilize new technology to build more coordinated teams and streamline operations and communications using tools such as CAD, Zoom, etc.
Building a culture of innovation
– managers at Dengvaxia Dengue can make experimentation a productive activity and build a culture of innovation using approaches such as – mining transaction data, A/B testing of websites and selling platforms, engaging potential customers over various needs, and building on small ideas in the Leadership & Managing People segment.
Reforming the budgeting process
- By establishing new metrics that will be used to evaluate both existing and potential projects Dengvaxia Dengue can not only reduce the costs of the project but also help it in integrating the projects with other processes within the organization.
Harnessing reconfiguration of the global supply chains
– As the trade war between US and China heats up in the coming years, Dengvaxia Dengue can build a diversified supply chain model across various countries in - South East Asia, India, and other parts of the world. This reconfiguration of global supply chain can help, as suggested in case study, Disrupting Dengue with an Emerging Markets Launch Strategy, to buy more products closer to the markets, and it can leverage its size and influence to get better deal from the local markets.
Low interest rates
– Even though inflation is raising its head in most developed economies, Dengvaxia Dengue can still utilize the low interest rates to borrow money for capital investment. Secondly it can also use the increase of government spending in infrastructure projects to get new business.
Leveraging digital technologies
– Dengvaxia Dengue can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.
Lowering marketing communication costs
– 5G expansion will open new opportunities for Dengvaxia Dengue in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the Leadership & Managing People segment, and it will provide faster access to the consumers.
Increase in government spending
– As the United States and other governments are increasing social spending and infrastructure spending to build economies post Covid-19, Dengvaxia Dengue can use these opportunities to build new business models that can help the communities that Dengvaxia Dengue operates in. Secondly it can use opportunities from government spending in Leadership & Managing People sector.
Loyalty marketing
– Dengvaxia Dengue has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.
Creating value in data economy
– The success of analytics program of Dengvaxia Dengue has opened avenues for new revenue streams for the organization in the industry. This can help Dengvaxia Dengue to build a more holistic ecosystem as suggested in the Disrupting Dengue with an Emerging Markets Launch Strategy case study. Dengvaxia Dengue can build new products and services such as - data insight services, data privacy related products, data based consulting services, etc.
Manufacturing automation
– Dengvaxia Dengue can use the latest technology developments to improve its manufacturing and designing process in Leadership & Managing People segment. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.
Remote work and new talent hiring opportunities
– The widespread usage of remote working technologies during Covid-19 has opened opportunities for Dengvaxia Dengue to expand its talent hiring zone. According to McKinsey Global Institute, 20% of the high end workforce in fields such as finance, information technology, can continously work from remote local post Covid-19. This presents a really great opportunity for Dengvaxia Dengue to hire the very best people irrespective of their geographical location.
Threats Disrupting Dengue with an Emerging Markets Launch Strategy External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The threats mentioned in the HBR case study Disrupting Dengue with an Emerging Markets Launch Strategy are -
Aging population
– As the populations of most advanced economies are aging, it will lead to high social security costs, higher savings among population, and lower demand for goods and services in the economy. The household savings in US, France, UK, Germany, and Japan are growing faster than predicted because of uncertainty caused by pandemic.
Environmental challenges
– Dengvaxia Dengue needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Dengvaxia Dengue can take advantage of this fund but it will also bring new competitors in the Leadership & Managing People industry.
Consumer confidence and its impact on Dengvaxia Dengue demand
– There is a high probability of declining consumer confidence, given – high inflammation rate, rise of gig economy, lower job stability, increasing cost of living, higher interest rates, and aging demography. All the factors contribute to people saving higher rate of their income, resulting in lower consumer demand in the industry and other sectors.
Easy access to finance
– Easy access to finance in Leadership & Managing People field will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. Dengvaxia Dengue can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.
Backlash against dominant players
– US Congress and other legislative arms of the government are getting tough on big business especially technology companies. The digital arm of Dengvaxia Dengue business can come under increasing regulations regarding data privacy, data security, etc.
Shortening product life cycle
– it is one of the major threat that Dengvaxia Dengue is facing in Leadership & Managing People sector. It can lead to higher research and development costs, higher marketing expenses, lower customer loyalty, etc.
Stagnating economy with rate increase
– Dengvaxia Dengue can face lack of demand in the market place because of Fed actions to reduce inflation. This can lead to sluggish growth in the economy, lower demands, lower investments, higher borrowing costs, and consolidation in the field.
Increasing wage structure of Dengvaxia Dengue
– Post Covid-19 there is a sharp increase in the wages especially in the jobs that require interaction with people. The increasing wages can put downward pressure on the margins of Dengvaxia Dengue.
High dependence on third party suppliers
– Dengvaxia Dengue high dependence on third party suppliers can disrupt its processes and delivery mechanism. For example -the current troubles of car makers because of chip shortage is because the chip companies started producing chips for electronic companies rather than car manufacturers.
Learning curve for new practices
– As the technology based on artificial intelligence and machine learning platform is getting complex, as highlighted in case study Disrupting Dengue with an Emerging Markets Launch Strategy, Dengvaxia Dengue may face longer learning curve for training and development of existing employees. This can open space for more nimble competitors in the field of Leadership & Managing People .
Trade war between China and United States
– The trade war between two of the biggest economies can hugely impact the opportunities for Dengvaxia Dengue in the Leadership & Managing People industry. The Leadership & Managing People industry is already at various protected from local competition in China, with the rise of trade war the protection levels may go up. This presents a clear threat of current business model in Chinese market.
High level of anxiety and lack of motivation
– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. Dengvaxia Dengue needs to understand the core reasons impacting the Leadership & Managing People industry. This will help it in building a better workplace.
Technology disruption because of hacks, piracy etc
– The colonial pipeline illustrated, how vulnerable modern organization are to international hackers, miscreants, and disruptors. The cyber security interruption, data leaks, etc can seriously jeopardize the future growth of the organization.
Weighted SWOT Analysis of Disrupting Dengue with an Emerging Markets Launch Strategy Template, Example
Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers in the HBR case study Disrupting Dengue with an Emerging Markets Launch Strategy needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants.
We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –
First stage for doing weighted SWOT analysis of the case study Disrupting Dengue with an Emerging Markets Launch Strategy is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.
Second stage for conducting weighted SWOT analysis of the Harvard case study Disrupting Dengue with an Emerging Markets Launch Strategy is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.
Third stage of constructing weighted SWOT analysis of Disrupting Dengue with an Emerging Markets Launch Strategy is to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Dengvaxia Dengue needs to make to build a sustainable competitive advantage.